No attachments available.
NonSurgical Debridement
Contact and place of performance
Jonathan Gonzalez, Contracting Officer
Washington, DC 20024
USA
This acquisition will allow BARDA to support procurement of an FDA-approved enzymatic debridement product and support development of a next generation product for increased preparedness value.
The Administration for Strategic Preparedness and Response (ASPR) issued award notice 75A50126C00002 to support the procurement of an FDA-approved enzymatic debridement product. This acquisition enables the Biomedical Advanced Research and Development Authority (BARDA) to enhance preparedness value by supporting the development of a next-generation product. Performance is located in Washington, DC, under the oversight of Contracting Officer Jonathan Gonzalez.
The project is classified under NAICS 541714 for Research and Development in Biotechnology (except Nanobiotechnology) and PSC 6510 for Surgical Dressing Materials. No set-aside was used for this award. The notice was published on April 2, 2026, and is designated as an award notice for the nonsurgical debridement efforts.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.